Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Express Scripts
Dow
Baxter
Moodys

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Aramchol

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Aramchol: Sponsors, patents, clinical trial progress

Aramchol is an investigational drug.

There have been 10 clinical trials for Aramchol. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2019.

The most common disease conditions in clinical trials are Fatty Liver, Non-alcoholic Fatty Liver Disease, and Liver Diseases. The leading clinical trial sponsors are Galmed Pharmaceuticals Ltd, Diamond PV Services Ltd, and Tel-Aviv Sourasky Medical Center.

There are six US patents protecting this investigational drug and seventy-four international patents.

Recent Clinical Trials for Aramchol
TitleSponsorPhase
A Phase 3/4 Clinical Study to Evaluate the Efficacy and Safety of Aramchol Versus Placebo in Subjects With NASH (ARMOR)Galmed Research and Development, Ltd.Phase 3
Comparison of Aramchol Concentrations With Once or Twice Daily DosingAnalyst Research LaboratoriesPhase 1
Comparison of Aramchol Concentrations With Once or Twice Daily DosingDiamond PV Services LtdPhase 1

See all Aramchol clinical trials

Clinical Trial Summary for Aramchol

Top disease conditions for Aramchol
Top clinical trial sponsors for Aramchol

See all Aramchol clinical trials

US Patents for Aramchol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Aramchol   Start Trial Bile salt conjugates Galmed International Limited (B'Kara, MT)   Start Trial
Aramchol   Start Trial Fatty acid derivatives of bile acids and bile acid derivatives Galmed International Limited (B'Kara, MT)   Start Trial
Aramchol   Start Trial Bile salt conjugates Galmed International Limited (B'Kara, MT)   Start Trial
Aramchol   Start Trial Bile acid or bile salt fatty acid conjugates Galmed International Limited (B'Kara, MT)   Start Trial
Aramchol   Start Trial Bile acid or bile salt fatty acid conjugates Galmed International Limited (B'Kara, MT)   Start Trial
Aramchol   Start Trial Bile acid or bile salt fatty acid conjugates Galmed Research and Development Ltd. (Tel-Aviv, IE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Aramchol

Drugname Country Document Number Estimated Expiration Related US Patent
Aramchol Austria 222923 2018-04-08   Start Trial
Aramchol Austria 365044 2018-04-08   Start Trial
Aramchol Austria 432705 2018-04-08   Start Trial
Aramchol Australia 2002307771 2018-04-08   Start Trial
Aramchol Australia 2007200191 2018-04-08   Start Trial
Aramchol Australia 2008249537 2018-04-08   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Mallinckrodt
Dow
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.